Licensed Practical Nurse in Seatac, WA Accepting Medicare

4 Licensed Practical Nurse nurses found. Showing 1 - 4

Sara Tilahun Eshete, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 14918 32nd Pl S, Seatac, WA 98168 Phone: 206-265-9599

Hibo Nura Samatar, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 4800 S 188th St Ste 240, Seatac, WA 98188 Phone: 206-957-2022

Ms. Angela Hockley, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 3452 S 164th St, Seatac, WA 98188 Phone: 206-433-2413

Rabeya Suraka, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 3425 S 176th St Unit 284, Seatac, WA 98188 Phone: 206-446-1272

News Archive

Greenway Medical Technologies to demonstrate data transfer solution from its EHR into Microsoft HealthVault

Greenway Medical Technologies, provider of the fully-integrated electronic health record (EHR), practice management and interoperability solution PrimeSuite®, is demonstrating a seamless data transfer solution from its flagship EHR into Microsoft HealthVault, an online personal health management platform.

Tapeworm infection drug blocks SARS-CoV-2 damage in the lungs

New research published in the journal Nature found the presence of SARS-CoV-2 in the lungs resulted in abnormal pneumocytes and spike protein-mediated cell fusion. Their findings also showed that TMEM16F protein activation induces cell fusion. Therefore, drugs inhibiting the TMEM16F/Anoctamin6 calcium-activated ion channel, such as niclosamide, could serve as potential treatments for reducing the severity of COVID-19 infection.

People with blindness from cataract are poorer than those with normal sight

A new study conducted in three developing countries-Kenya, the Philippines, and Bangladesh-finds that people with cataract-induced visual impairment are more likely to live in poverty than those with normal sight.

Visterra gets $8.1M in proceeds from upsized and final closing of Series A financing round

Visterra, Inc., a developer of novel therapeutics to prevent and treat major infectious diseases, today announced that it has received $8.1 million in proceeds from an upsized and final closing of its Series A financing round. The company also announced that it has deepened its executive management team by appointing two industry veterans to newly created roles, which follows the recent appointment of Brian Pereira, M.D. as President and Chief Executive Officer of Visterra this past summer.

Read more Medical News

› Verified 2 days ago